C2T-48827-38145
4 vaccinations
2 coded responses
43 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 891 / NV
- Registered
- 2021-04-29
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Registered dependents
932-25311-59425
Child or adolescent in my care · Female · 2022-11-02
Timeline
-
2021-04-08
Dose 1 — Pfizer-BioNTech
-
2021-04-29
Registered in v-safe
-
2021-04-29
Dose 2 — Pfizer-BioNTech
- 2021-04-29
-
2021-04-30
Survey response — days 1–6 daily, dose 2MedDRA: Chills, Hyperhidrosis, Pyrexia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Unusual and prolonged delay in the onset of sweating that I normally experience following about of chills then feeling feverish. Urination frequency and amount remained normal throughout the entire presentation of symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-01
- 2021-05-03
- 2021-05-04
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-06-03
- 2021-06-10
- 2021-07-29
- 2021-10-28
-
2022-02-21
Dose 3 — Pfizer-BioNTechCo-administered: Tetanus
- 2022-02-21
-
2022-02-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body achesAdult check-in
- 2022-02-23
- 2022-02-24
- 2022-02-25
- 2022-02-26
- 2022-02-27
- 2022-02-28
- 2022-03-07
- 2022-03-14
- 2022-03-21
- 2022-03-28
- 2022-04-04
- 2022-05-23
- 2022-08-22
-
2022-10-07
Dose 4 — ModernaCo-administered: Flu
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2022-11-19
- 2023-01-06
- 2023-04-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Pfizer-BioNTech | |
| 2 | 2021-04-29 | Pfizer-BioNTech | |
| 3 | 2022-02-21 | Pfizer-BioNTech | Tetanus |
| 4 | 2022-10-07 | Moderna | Flu |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Unusual and prolonged delay in the onset of sweating that I normally experience following about of chills then feeling feverish. Urination frequency and amount remained normal throughout the entire presentation of symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Malaise | · | · | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release